Singapore Partners with Google DeepMind to Boost AI in Healthcare and Beyond
In brief
- Singapore is teaming up with Google DeepMind to harness cutting-edge artificial intelligence for significant societal advancements.
- The partnership focuses on enhancing healthcare, accelerating scientific discoveries, and transforming education through AI.
- Key initiatives include an AI co-clinician program that supports doctors by providing evidence-based insights and a pandemic preparedness effort using tools like AlphaFold.
- These projects aim to address real-world challenges while fostering economic growth.
- By 2040, AI could add S$3.3 billion to Singapore's economy through faster R&D.
- The collaboration underscores Singapore's commitment to responsibly deploying AI for public benefit and economic progress.
Terms in this brief
- AlphaFold
- A tool developed by DeepMind that predicts protein structures using AI, aiding in scientific discoveries and understanding life's building blocks. It has revolutionized biology by solving complex puzzles quickly and accurately.
Read full story at DeepMind Safety →
More briefs
Meta Lays Off 8,000 Employees
Meta laid off 8,000 employees to offset its AI investments. This is around 10 percent of the company. The company is spending a lot of money on AI. It plans to spend $115 billion to $135 billion in 2026. This is almost double what it spent in 2025. Meta is also moving employees to work on new AI projects. The layoffs are now underway and some employees have posted about it on LinkedIn. Meta will continue to make changes to its business.
Pharma Companies Partner with AI Firms
Eli Lilly and Bristol Myers Squibb have partnered with AI companies to improve drug development. Bristol Myers Squibb will use Anthropic's Claude model to streamline workflows and improve data analysis. Lilly will integrate its AI engine into Collaborative Drug Discovery's database to share research data with other companies. This will give biotechs access to decades of Lilly's research data to train their models. New partnerships will help the biopharma industry use artificial intelligence to develop new drugs faster. The industry will continue to change with more AI deals in the future.
OpenAI Poised for IPO Amid Major Milestone
OpenAI is on the brink of a significant financial move, with reports indicating it could file confidential IPO paperwork with the SEC within days. This decision comes as the company continues to expand its influence in artificial intelligence and faces increasing pressure to monetize its innovations. If OpenAI proceeds with the IPO, it would mark a major turning point for the AI industry. The company's groundbreaking work has set the standard for AI development, and going public could provide much-needed funding for further research while potentially making AI more accessible to businesses and developers worldwide. While there’s no official confirmation yet, this move could pave the way for other AI-focused startups to follow suit. Stay tuned for updates on how this could reshape the tech landscape in the coming months.
Samsung Workers Suspend Strike Over AI Bonus Dispute
Samsung workers have suspended a planned strike after reaching a tentative pay agreement with the company. The strike was due to begin on Thursday and would have affected nearly 48,000 workers. The dispute was over how to distribute profits from AI memory chip sales. The union wanted bonuses for all workers, not just those making memory chips. Samsung had planned to pay memory chip workers at least six times more than other workers. The strike suspension will ease fears of disruption to the global technology industry, which relies on Samsung for memory chips. Samsung will now wait for workers to vote on the deal from 22-27 May.
Swiss Cloud Company Transfers Majority Voting Rights to Public-Interest Foundation
Infomaniak, a Swiss cloud service provider known for its commitment to privacy and sustainability, has transferred the majority of its voting rights to the Infomaniak Foundation. This move ensures the company remains independent and true to its values, even as it faces growing challenges from AI, takeovers, and geopolitical tensions. The foundation now holds special shares that cannot be transferred, giving it permanent control. This change strengthens Infomaniak's long-term stability and secures its mission for future generations.